Abstract
Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone), which entered several phase I and II clinical trials as an antitumor chemotherapeutic agent, was found to possess intrinsic fluorescence properties (lambda(ex) = 360 nm), which enabled us to monitor the uptake and intracellular distribution in living human cancer cells by fluorescence microscopy.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Agents / chemistry*
-
Antineoplastic Agents / metabolism*
-
Antineoplastic Agents / pharmacology
-
Cell Line, Tumor
-
Cell Survival / drug effects
-
Fluorescence*
-
Humans
-
Microscopy, Fluorescence
-
Organometallic Compounds / chemistry*
-
Organometallic Compounds / metabolism*
-
Organometallic Compounds / pharmacology
-
Pyridines / chemistry*
-
Thiosemicarbazones / chemistry*
-
Zinc / chemistry*
Substances
-
Antineoplastic Agents
-
Organometallic Compounds
-
Pyridines
-
Thiosemicarbazones
-
3-aminopyridine-2-carboxaldehyde thiosemicarbazone
-
Zinc